MDMA, more commonly known as ecstasy, is classified as a Schedule 1 drug, which is a category reserved for compounds with no accepted medical use and a high abuse potential. But in a commentary published in Cell, two researchers from Stanford call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.
MDMA is described as an "empathogen," a compound that promotes feelings of empathy and close positive social feelings in users. The drug is a strictly regulated along with drugs such as heroin and LSD. However, MDMA's regulated status shouldn't discourage researchers from studying its effects, argue the Stanford scientists.
Poll Question:
MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA’s effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.
Do you agree that ecstasy should be studied for its potential therapeutic benefits?
Yes
297
No
36
